We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+0.26%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$30.7B
AUM Growth
+$988M
(+3.3%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.28%
Top 10 Holdings %
Top 10 Hldgs %
54.65%
Holding
2,179
New
164
Increased
802
Reduced
752
Closed
188
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$124M |
| 2 |
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
|
+$122M |
| 3 |
Alerian MLP ETF
AMLP
|
+$112M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$84.3M |
| 5 |
Schwab International Equity ETF
SCHF
|
+$75.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$92.7M |
| 2 |
TSS
Total System Services, Inc.
TSS
|
+$49.4M |
| 3 |
Vanguard Mid-Cap ETF
VO
|
+$25.4M |
| 4 |
Schwab US REIT ETF
SCHH
|
+$23.4M |
| 5 |
Apple
AAPL
|
+$14.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.77% |
| 2 | Technology | 4.11% |
| 3 | Healthcare | 1.86% |
| 4 | Consumer Discretionary | 1.76% |
| 5 | Industrials | 1.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Boston Scientific
BSX
$65.8B
| $2.59M | 0.01% |
63,666
+1,296
| +2% | +$54.9K |
|
427
Hershey
HSY
$35.4B
| $2.58M | 0.01% |
16,653
-1,065
| -6% | -$161K |
|
428
Avista
AVA
$3.47B
| $2.56M | 0.01% |
52,903
-3,847
| -7% | -$179K |
|
429
Western Digital
WDC
$179B
| $2.54M | 0.01% |
56,437
-8,272
| -13% | -$353K |
|
430
Lincoln Electric
LECO
$13.8B
| $2.53M | 0.01% |
29,168
-1,000
| -3% | -$84.2K |
|
431
iShares US Aerospace & Defense ETF
ITA
$14.2B
| $2.52M | 0.01% |
22,446
-910
| -4% | -$99.5K |
|
432
Vanguard S&P 500 Growth ETF
VOOG
$25.4B
| $2.5M | 0.01% |
92,958
-2,886
| -3% | -$78.2K |
|
433
Vanguard Financials ETF
VFH
$13.3B
| $2.5M | 0.01% |
35,710
-1,274
| -3% | -$88K |
|
434
Teva Pharmaceuticals
TEVA
$35.9B
| $2.49M | 0.01% |
362,464
+178,022
| +97% | +$1.36M |
|
|
ABMD
435
DELISTED
Abiomed Inc
ABMD
| $2.47M | 0.01% |
13,888
+8,810
| +173% | +$1.9M |
|
436
Ameren
AEE
$31.5B
| $2.47M | 0.01% |
30,820
-4,128
| -12% | -$317K |
|
|
SASR
437
DELISTED
Sandy Spring Bancorp Inc
SASR
| $2.46M | 0.01% |
72,895
-5,560
| -7% | -$193K |
|
438
Advanced Micro Devices
AMD
$851B
| $2.45M | 0.01% |
84,494
-14,036
| -14% | -$440K |
|
439
Skywest
SKYW
$4.11B
| $2.44M | 0.01% |
42,506
-41
| -0.1% | -$2.41K |
|
440
Cracker Barrel
CBRL
$1.2B
| $2.4M | 0.01% |
14,752
+777
| +6% | +$131K |
|
441
Lamb Weston
LW
$6.85B
| $2.4M | 0.01% |
32,992
-4,517
| -12% | -$310K |
|
|
ONCT
442
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $2.39M | 0.01% |
+23,872
| New | +$2.44M |
|
443
Unilever
UL
$131B
| $2.37M | 0.01% |
35,024
+1,266
| +4% | +$87.7K |
|
444
McKesson
MCK
$98.5B
| $2.36M | 0.01% |
17,275
-727
| -4% | -$103K |
|
445
Microchip Technology
MCHP
$42.8B
| $2.36M | 0.01% |
50,716
+492
| +1% | +$22.3K |
|
446
Trane Technologies
TT
$106B
| $2.35M | 0.01% |
19,032
+625
| +3% | +$76.3K |
|
447
Genesis Energy
GEL
$1.84B
| $2.34M | 0.01% |
108,989
-4,994
| -4% | -$108K |
|
448
Selective Insurance
SIGI
$5.77B
| $2.33M | 0.01% |
31,052
-47
| -0.2% | -$3.63K |
|
449
Las Vegas Sands
LVS
$30.5B
| $2.32M | 0.01% |
40,210
+7,745
| +24% | +$451K |
|
450
Invesco S&P 500 Low Volatility ETF
SPLV
$7.2B
| $2.32M | 0.01% |
40,088
-1,913
| -5% | -$108K |
|
Similar funds
Creative Planning's Q3 2019 Portfolio in Review
As of Q3 2019, Creative Planning held 2,179 positions worth $30.7B, up 3.3% from $29.7B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Creative Planning deployed $1.01B of net new capital in Q3 2019, opening 164 new positions and adding to 802 existing holdings. Its largest new stake was Oncternal Therapeutics, Inc. Common Stock: 23,872 shares worth $2.39M.
By sector, the portfolio is most concentrated in Financials at 4.8% of assets, down from 4.9% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $92.7M trimmed.
- Creative Planning's largest Q3 2019 buy was Oncternal Therapeutics, Inc. Common Stock: 23,872 shares worth $2.39M.
- Creative Planning added most to iShares Core US Aggregate Bond ETF in Q3 2019, an estimated $124M increase.
- Creative Planning's biggest Q3 2019 reduction was JP Morgan Alerian MLP Index ETN 5/24/24, cutting an estimated $92.7M.
- Creative Planning fully exited Total System Services, Inc. in Q3 2019, selling an estimated $49.4M.
- Creative Planning's ten largest holdings make up 55% of its $30.7B portfolio in Q3 2019.
- Creative Planning opened 164 new positions and closed 188 in Q3 2019.
- Creative Planning's portfolio value rose 3.3% quarter-over-quarter to $30.7B.
Based on Creative Planning's 13F filing for Q3 2019, filed 1 Nov 2019.